Abstract

Objectives Cervical cancer (CC) is one of the most destructive disease caused by persistent HPV infection which affects women worldwide, especially in developing countries. The genetic basis of host immune response especially cytokine function has been shown to influence CC susceptibility. Studies have demonstrated that IL-10 gene polymorphism have been associated with numerous malignancies, but in context to CC results were inconclusive. Though, aim of our study to investigate the association between IL-10 -1082A/G and -819C/T promoter polymorphism and CC susceptibility. Material and Methods This study comprised 192 women with CC and 200 controls. HPV detection was done by RT-PCR and genotyping was assessed through PCR-RFLP method. Serum concentration of IL-10 measured by ELISA. Results Women with AG and AG+GG genotypes of IL-10 -1082A/G had two-fold increased risk of CC [OR, 2.35 (95% CI, 1.54–3.58), p = 0.005], [OR, 2.03 (95% CI, 1.36–3.04), p = 0.0005] compared to controls. Women with G allele of -1082A/G polymorphism had linked with CC susceptibility [OR, 1.39 (95% CI, 1.02–1.88), p = 0.036] compared to controls. No significant difference was found between patients and controls in the genotype or allele frequencies of IL–10 -819C/T polymorphism [OR, 1.00 (95% CI, 0.63–1.58), p = 0.99]. The level of serum concentration of IL-10 was significantly higher in cases compared to controls. Conclusion These findings help to understand that polymorphism of IL-10 -1082A/G gene is associated with increased risk of CC development and can serve as a marker of genetic susceptibility to CC.

Highlights

  • Cervical cancer (CC) is one of the most fatal malignancies among females and is recognized as the second most common cancer globally.[1]

  • Women with G allele of -1082A/G polymorphism had linked with CC susceptibility [odds ratio (OR), 1.39, p 1⁄4 0.036] compared to controls

  • No significant difference was found between patients and controls in the genotype or allele frequencies of IL–10 -819C/T polymorphism [OR, 1.00, p 1⁄4 0.99]

Read more

Summary

Introduction

Cervical cancer (CC) is one of the most fatal malignancies among females and is recognized as the second most common cancer globally.[1] Overall, it is recognized as the fourth most common type of malignancy and frequently occurs in the lower end of the uterine cervix, affecting normal cervix epithelial tissues and causing aberrant changes in the deeper tissues.[2,3,4] CC affects more than half a million women annually, culminating in more than 570,000 diagnosis and 300,000 fatalities worldwide as per WHO reports. 90% of CC patients emerge within low- and middleincome countries.[5,6] There are $365.71 million women in India over the age of 15 years who are at risk of CC. Indian women have a 2.5% lifetime risk of CC and a 1.4% lifetime risk of mortality from CC.[7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call